Signalling intermediates of CD28.
Ben-Neriah
Y
Y
Lautenberg Center for General and Tumor Immunology, Jerusalem.
Alkalay
I
I
Yaron
A
A
Hatzubai
A
A
Jung
S
S
D000818:Animals; D001665:Binding Sites; D018106:CD28 Antigens / Q000378:metabolism*; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000276:immunology; D006801:Humans; D048031:JNK Mitogen-Activated Protein Kinases; D008213:Lymphocyte Activation; D020928:Mitogen-Activated Protein Kinases; D008954:Models, Biological; D016328:NF-kappa B / Q000276:immunology; D016755:Proto-Oncogene Proteins c-jun / Q000276:immunology; D015398:Signal Transduction / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology
D018106:CD28 Antigens; D016328:NF-kappa B; D016755:Proto-Oncogene Proteins c-jun; D017871:Calcium-Calmodulin-Dependent Protein Kinases; D048031:JNK Mitogen-Activated Protein Kinases; D020928:Mitogen-Activated Protein Kinases